This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks Drop as Jobs Pop Is Offset by Troubling Details

NEW YORK (TheStreet) -- U.S. stocks closed lower Friday, erasing early gains after April's jobs report showed a falling work force participation rate. The United Nations held an emergency meeting over Ukraine as tensions rose in the region.  

  • The Dow Jones Industrial Average fell 0.28% to 16,512.89, while the S&P 500 was 0.13% lower to 1,881.14. The Nasdaq dropped 0.09% to 4,123.90. The Dow, S&P and Nasdaq for the week gained 0.93%, 0.95% and 1.19%, respectively.
  • The U.S. created 288,000 jobs in April vs. the average economist's estimate of 210,000, the Bureau of Labor Statistics reported Friday. The jobless rate fell to 6.3% vs. expectations of a fall to 6.6%. But commentators pointed to the report's details. "The sharp drop in joblessness must be taken with a pinch of salt as the cast of unemployed did not necessarily find work -- they may have simply stopped looking," Interactive Brokers chief market analyst Andrew Wilkinson told clients. "Proving the case is the drop in the participation rate to 62.8% from 63.2%."
  • The United Nations Security Council was holding an emergency meeting after Russia's request. Ukraine tensions continued as the country sent armored vehicles to retake a city which is a stronghold for pro-separatist forces. President Obama and German Chancellor Angela Merkel warned Russia on  Friday not to disrupt the this month's presidential elections in Ukraine.
  • March factory orders increased 1.1% in March, below forecasts for a 1.5% advance.
  • Marsh & McLennan (MMC) dropped 1.4% after first-quarter earnings of 81 cents a share topped expectations by a penny.
  • Chevron (CVX - Get Report) was off 0.18% after it said earnings fell 27% in the first quarter due to lower oil prices and bad weather.
  • LinkedIn (LNKD) shed 8.4% after issuing guidance on Thursday short of analysts' estimates after it said it swung to a loss in the first quarter ended in March.
  • AstraZeneca (AZN) edged 0.09% lower after rejecting Pfizer's (PFE - Get Report) sweetened bid that values AstraZeneca at $106 billion.
  • Merck (MRK) shares slid 2.4%. The stock was also being closely watched as the FDA asks a panel of advisers to vote on Friday on whether Singulair is safe enough to be approved for nonprescription use. Bloomberg reported that Bayer is in exclusive talks to acquire Merck's consumer business and is prepared to pay about $14 billion for the division.
  • The euro-area unemployment rate remained at a near record high in March, with a jobless rate of 11.8%, the European Union's statistics office said Friday. Germany's DAX closed 0.49% lower while the FTSE was 0.2% higher. The Hang Seng closed 0.57% higher while the Nikkei was 0.19% lower.

-- By Jane Searle, Andrea Tse and Joe Deaux in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CVX $106.44 2.10%
PFE $35.04 1.50%
AAPL $125.77 2.00%
FB $83.40 0.12%
GOOG $551.56 0.59%

Markets

DOW 17,999.87 +287.21 1.62%
S&P 500 2,087.13 +26.11 1.27%
NASDAQ 4,944.7330 +53.5140 1.09%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs